TY - JOUR
T1 - Examining risk factors and preventive treatments for first venous leg ulceration
T2 - A cohort study
AU - Darwin, Evan
AU - Liu, Guodong
AU - Kirsner, Robert S.
AU - Lev-Tov, Hadar
N1 - Funding Information:
Funding sources: Supported by a Dermatology Foundation and University of Miami award to Dr Lev-Tov.
Publisher Copyright:
© 2020
PY - 2021/1
Y1 - 2021/1
N2 - Background: Large studies that examine risk factors for first occurrence of venous leg ulcerations are needed to guide management. Objective: To investigate factors associated with development of first occurrence of venous leg ulcerations. Methods: A retrospective cohort study using a validated national commercial claims database of patients with venous insufficiency. Subjects were followed to determine whether they developed first occurrence of venous leg ulcerations, and risk and protective factors were analyzed. Results: Adjusted hazard ratio (AHR) for comorbidities demonstrated an increased risk in men (AHR 1.838; 95% confidence interval [CI] 1.798-1.880), older age (45-54 years: AHR 1.316, 95% CI 1.276-1.358; 55-64 years, AHR 1.596, 95% CI 1.546-1.648), history of nonvenous leg ulceration (AHR 3.923; 95% CI 3.699-4.161), anticoagulant use (AHR 1.199; 95% CI 1.152-1.249), antihypertensive use (AHR 1.067; 95% CI 1.040-1.093), and preexisting venous insufficiency including chronic venous insufficiency (AHR 1.244; 95% CI 1.193-1.298), edema (AHR 1.224; 95% CI 1.193-1.256), and chronic venous hypertension (AHR 1.671; 95% CI 1.440-1.939). Possible protective factors were having venous surgery (AHR 0.454; 95% CI 0.442-0.467), using compression stockings (AHR 0.728; 95% CI 0.705-0.753), using prescribed statin medications (AHR 0.721; 95% CI 0.700-0.743), and using pain medications (AHR 0.779; 95% CI 0.757-0.777). Limitations: Risk of misclassification, given the use of International Classification of Diseases, Ninth Revision codes. Possible confounding factors such as body mass index could not be adequately controlled with these codes. Conclusion: The new evidence presented supports a paradigm shift toward venous leg ulceration prevention.
AB - Background: Large studies that examine risk factors for first occurrence of venous leg ulcerations are needed to guide management. Objective: To investigate factors associated with development of first occurrence of venous leg ulcerations. Methods: A retrospective cohort study using a validated national commercial claims database of patients with venous insufficiency. Subjects were followed to determine whether they developed first occurrence of venous leg ulcerations, and risk and protective factors were analyzed. Results: Adjusted hazard ratio (AHR) for comorbidities demonstrated an increased risk in men (AHR 1.838; 95% confidence interval [CI] 1.798-1.880), older age (45-54 years: AHR 1.316, 95% CI 1.276-1.358; 55-64 years, AHR 1.596, 95% CI 1.546-1.648), history of nonvenous leg ulceration (AHR 3.923; 95% CI 3.699-4.161), anticoagulant use (AHR 1.199; 95% CI 1.152-1.249), antihypertensive use (AHR 1.067; 95% CI 1.040-1.093), and preexisting venous insufficiency including chronic venous insufficiency (AHR 1.244; 95% CI 1.193-1.298), edema (AHR 1.224; 95% CI 1.193-1.256), and chronic venous hypertension (AHR 1.671; 95% CI 1.440-1.939). Possible protective factors were having venous surgery (AHR 0.454; 95% CI 0.442-0.467), using compression stockings (AHR 0.728; 95% CI 0.705-0.753), using prescribed statin medications (AHR 0.721; 95% CI 0.700-0.743), and using pain medications (AHR 0.779; 95% CI 0.757-0.777). Limitations: Risk of misclassification, given the use of International Classification of Diseases, Ninth Revision codes. Possible confounding factors such as body mass index could not be adequately controlled with these codes. Conclusion: The new evidence presented supports a paradigm shift toward venous leg ulceration prevention.
UR - http://www.scopus.com/inward/record.url?scp=85080091991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080091991&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2019.12.046
DO - 10.1016/j.jaad.2019.12.046
M3 - Article
C2 - 31884088
AN - SCOPUS:85080091991
SN - 0190-9622
VL - 84
SP - 76
EP - 85
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -